Adjuvant Therapy in Stage I Testicular Cancer: Surveillance for All

Stephan Brönimann1, Nirmish Singla2

  • 1Department of Urology, The Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Oncology, The Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Urology, Medical University of Vienna, Vienna, Austria.

PubMed

Related Concept Videos